Allomap Testing
> http://www.vanderbilthealth.comtransplant/11428 <
> http://www.vanderbilthealth.comtransplant/11428 <
AlloMap testing is a noninvasive method for determining the risk of acute cellular rejection (ACR) in heart transplant recipients. The test translates the complex signals of the immune system’s multiple genes and pathways, specifically those associated with heart transplant ACR, into an objective, actionable score. 

AlloMap testing is a safe, convenient and proven new method to significantly improve heart transplant recipients’ satisfaction. Rather than having an invasive procedure in a heart catheterization lab, only a simple and quick blood draw is necessary. The blood sample is sent to the XDx clinical laboratory, a state-of-the-art clinical lab in Brisbane, where complex gene information is extracted and analyzed. Using the XDx proprietary algorithm, the information is translated into a single score that distinguishes rejection from quiescence, or a stable state. Read more. Allomap Protocol
Editorial : How Sweet it Is ! Biopsy`s are not very much fun. Allomap is the way ! Hoo-Ray ! This from a Heart-Transplant patient almost 16 years post ! Hey That`s ME !
No comments:
Post a Comment